Synthesis and biological evaluation of [18F]fluorovinpocetine, a potential PET radioligand for TSPO imaging. Nag, S., Krasikova, R., Airaksinen, A., Arakawa, R., Petukhovd, M., & Gulyas, B. Bioorganic and Medicinal Chemistry Letters, 29(16):2270-2274, Elsevier Ltd, 2019. cited By 0
Paper doi abstract bibtex Despite of various PET radioligands targeting the translocator protein TSPO 18-KDa are used for the investigations of neuroinflammatory conditions associated with neurological disorders, development of new TSPO radiotracers is still an active area of the researches with a major focus on the 18F-labelled radiotracers. Here, we report the radiochemical synthesis of [18F]vinpocetine, fluorinated analogue of previously reported TSPO radioligand, [11C]vinpocetine. Radiolabeling was achieved by [18F]fluoroethylation of apovincaminic acid with [18F]fluoroethyl bromide. [18F]vinpocetine was obtained in quantities >2.7 GBq in RCY of 13% (non–decay corrected), and molar activity >60 GBq/µmol within 95 min synthesis time. Preliminary PET studies in a cynomolgus monkey and metabolite studies by HPLC demonstrated similar results by [18F]vinpocetine as for [11C]vinpocetine, including high blood-brain barrier permeability, regional uptake pattern and fast washout from the NHP brain. These results demonstrate that [18F]fluorovinpocetine warrants further evaluation as an easier accessible alternative to [11C]vinpocetine. © 2019 Elsevier Ltd
@ARTICLE{Nag20192270,
author={Nag, S. and Krasikova, R. and Airaksinen, A.J. and Arakawa, R. and Petukhovd, M. and Gulyas, B.},
title={Synthesis and biological evaluation of [18F]fluorovinpocetine, a potential PET radioligand for TSPO imaging},
journal={Bioorganic and Medicinal Chemistry Letters},
year={2019},
volume={29},
number={16},
pages={2270-2274},
doi={10.1016/j.bmcl.2019.06.037},
note={cited By 0},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067891805&doi=10.1016%2fj.bmcl.2019.06.037&partnerID=40&md5=039425a06c8d92bde0fe18f6ade9f6de},
affiliation={Karolinska Institutet, Department of Clinical Neuroscience, Stockholm, Sweden; N.P. Bechtereva Institute of Human Brain Russian Academy of Sciences, St.-Petersburg, Russian Federation; Department of Chemistry – Radiochemistry, University of Helsinki, Finland; Petersburg Nuclear Physics Institute named after B.P. Konstantinov, NRC “Kurchatov Institute”, Gatchina, Russian Federation; Peter the Great St.-Petersburg Polytechnic University, St.-Petersburg, Russian Federation; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore},
abstract={Despite of various PET radioligands targeting the translocator protein TSPO 18-KDa are used for the investigations of neuroinflammatory conditions associated with neurological disorders, development of new TSPO radiotracers is still an active area of the researches with a major focus on the 18F-labelled radiotracers. Here, we report the radiochemical synthesis of [18F]vinpocetine, fluorinated analogue of previously reported TSPO radioligand, [11C]vinpocetine. Radiolabeling was achieved by [18F]fluoroethylation of apovincaminic acid with [18F]fluoroethyl bromide. [18F]vinpocetine was obtained in quantities >2.7 GBq in RCY of 13% (non–decay corrected), and molar activity >60 GBq/µmol within 95 min synthesis time. Preliminary PET studies in a cynomolgus monkey and metabolite studies by HPLC demonstrated similar results by [18F]vinpocetine as for [11C]vinpocetine, including high blood-brain barrier permeability, regional uptake pattern and fast washout from the NHP brain. These results demonstrate that [18F]fluorovinpocetine warrants further evaluation as an easier accessible alternative to [11C]vinpocetine. © 2019 Elsevier Ltd},
author_keywords={Fluorine-18; Kinetics; Monkey; PET; Radiometabolites; TSPO radioligands; Vinpocetine},
correspondence_address1={Nag, S.; Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Karolinska HospitalSweden; email: sangram.nag@ki.se},
publisher={Elsevier Ltd},
issn={0960894X},
coden={BMCLE},
pubmed_id={31257082},
language={English},
abbrev_source_title={Bioorg. Med. Chem. Lett.},
document_type={Article},
source={Scopus},
}
Downloads: 0
{"_id":"GP7GYvy2W9YdkELkW","bibbaseid":"nag-krasikova-airaksinen-arakawa-petukhovd-gulyas-synthesisandbiologicalevaluationof18ffluorovinpocetineapotentialpetradioligandfortspoimaging-2019","author_short":["Nag, S.","Krasikova, R.","Airaksinen, A.","Arakawa, R.","Petukhovd, M.","Gulyas, B."],"bibdata":{"bibtype":"article","type":"article","author":[{"propositions":[],"lastnames":["Nag"],"firstnames":["S."],"suffixes":[]},{"propositions":[],"lastnames":["Krasikova"],"firstnames":["R."],"suffixes":[]},{"propositions":[],"lastnames":["Airaksinen"],"firstnames":["A.J."],"suffixes":[]},{"propositions":[],"lastnames":["Arakawa"],"firstnames":["R."],"suffixes":[]},{"propositions":[],"lastnames":["Petukhovd"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Gulyas"],"firstnames":["B."],"suffixes":[]}],"title":"Synthesis and biological evaluation of [18F]fluorovinpocetine, a potential PET radioligand for TSPO imaging","journal":"Bioorganic and Medicinal Chemistry Letters","year":"2019","volume":"29","number":"16","pages":"2270-2274","doi":"10.1016/j.bmcl.2019.06.037","note":"cited By 0","url":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067891805&doi=10.1016%2fj.bmcl.2019.06.037&partnerID=40&md5=039425a06c8d92bde0fe18f6ade9f6de","affiliation":"Karolinska Institutet, Department of Clinical Neuroscience, Stockholm, Sweden; N.P. Bechtereva Institute of Human Brain Russian Academy of Sciences, St.-Petersburg, Russian Federation; Department of Chemistry – Radiochemistry, University of Helsinki, Finland; Petersburg Nuclear Physics Institute named after B.P. Konstantinov, NRC “Kurchatov Institute”, Gatchina, Russian Federation; Peter the Great St.-Petersburg Polytechnic University, St.-Petersburg, Russian Federation; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore","abstract":"Despite of various PET radioligands targeting the translocator protein TSPO 18-KDa are used for the investigations of neuroinflammatory conditions associated with neurological disorders, development of new TSPO radiotracers is still an active area of the researches with a major focus on the 18F-labelled radiotracers. Here, we report the radiochemical synthesis of [18F]vinpocetine, fluorinated analogue of previously reported TSPO radioligand, [11C]vinpocetine. Radiolabeling was achieved by [18F]fluoroethylation of apovincaminic acid with [18F]fluoroethyl bromide. [18F]vinpocetine was obtained in quantities >2.7 GBq in RCY of 13% (non–decay corrected), and molar activity >60 GBq/µmol within 95 min synthesis time. Preliminary PET studies in a cynomolgus monkey and metabolite studies by HPLC demonstrated similar results by [18F]vinpocetine as for [11C]vinpocetine, including high blood-brain barrier permeability, regional uptake pattern and fast washout from the NHP brain. These results demonstrate that [18F]fluorovinpocetine warrants further evaluation as an easier accessible alternative to [11C]vinpocetine. © 2019 Elsevier Ltd","author_keywords":"Fluorine-18; Kinetics; Monkey; PET; Radiometabolites; TSPO radioligands; Vinpocetine","correspondence_address1":"Nag, S.; Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Karolinska HospitalSweden; email: sangram.nag@ki.se","publisher":"Elsevier Ltd","issn":"0960894X","coden":"BMCLE","pubmed_id":"31257082","language":"English","abbrev_source_title":"Bioorg. Med. Chem. Lett.","document_type":"Article","source":"Scopus","bibtex":"@ARTICLE{Nag20192270,\r\nauthor={Nag, S. and Krasikova, R. and Airaksinen, A.J. and Arakawa, R. and Petukhovd, M. and Gulyas, B.},\r\ntitle={Synthesis and biological evaluation of [18F]fluorovinpocetine, a potential PET radioligand for TSPO imaging},\r\njournal={Bioorganic and Medicinal Chemistry Letters},\r\nyear={2019},\r\nvolume={29},\r\nnumber={16},\r\npages={2270-2274},\r\ndoi={10.1016/j.bmcl.2019.06.037},\r\nnote={cited By 0},\r\nurl={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067891805&doi=10.1016%2fj.bmcl.2019.06.037&partnerID=40&md5=039425a06c8d92bde0fe18f6ade9f6de},\r\naffiliation={Karolinska Institutet, Department of Clinical Neuroscience, Stockholm, Sweden; N.P. Bechtereva Institute of Human Brain Russian Academy of Sciences, St.-Petersburg, Russian Federation; Department of Chemistry – Radiochemistry, University of Helsinki, Finland; Petersburg Nuclear Physics Institute named after B.P. Konstantinov, NRC “Kurchatov Institute”, Gatchina, Russian Federation; Peter the Great St.-Petersburg Polytechnic University, St.-Petersburg, Russian Federation; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore},\r\nabstract={Despite of various PET radioligands targeting the translocator protein TSPO 18-KDa are used for the investigations of neuroinflammatory conditions associated with neurological disorders, development of new TSPO radiotracers is still an active area of the researches with a major focus on the 18F-labelled radiotracers. Here, we report the radiochemical synthesis of [18F]vinpocetine, fluorinated analogue of previously reported TSPO radioligand, [11C]vinpocetine. Radiolabeling was achieved by [18F]fluoroethylation of apovincaminic acid with [18F]fluoroethyl bromide. [18F]vinpocetine was obtained in quantities >2.7 GBq in RCY of 13% (non–decay corrected), and molar activity >60 GBq/µmol within 95 min synthesis time. Preliminary PET studies in a cynomolgus monkey and metabolite studies by HPLC demonstrated similar results by [18F]vinpocetine as for [11C]vinpocetine, including high blood-brain barrier permeability, regional uptake pattern and fast washout from the NHP brain. These results demonstrate that [18F]fluorovinpocetine warrants further evaluation as an easier accessible alternative to [11C]vinpocetine. © 2019 Elsevier Ltd},\r\nauthor_keywords={Fluorine-18; Kinetics; Monkey; PET; Radiometabolites; TSPO radioligands; Vinpocetine},\r\ncorrespondence_address1={Nag, S.; Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Karolinska HospitalSweden; email: sangram.nag@ki.se},\r\npublisher={Elsevier Ltd},\r\nissn={0960894X},\r\ncoden={BMCLE},\r\npubmed_id={31257082},\r\nlanguage={English},\r\nabbrev_source_title={Bioorg. Med. Chem. Lett.},\r\ndocument_type={Article},\r\nsource={Scopus},\r\n}\r\n\r\n","author_short":["Nag, S.","Krasikova, R.","Airaksinen, A.","Arakawa, R.","Petukhovd, M.","Gulyas, B."],"key":"Nag20192270","id":"Nag20192270","bibbaseid":"nag-krasikova-airaksinen-arakawa-petukhovd-gulyas-synthesisandbiologicalevaluationof18ffluorovinpocetineapotentialpetradioligandfortspoimaging-2019","role":"author","urls":{"Paper":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067891805&doi=10.1016%2fj.bmcl.2019.06.037&partnerID=40&md5=039425a06c8d92bde0fe18f6ade9f6de"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bio.pnpi.nrcki.ru/wp-content/uploads/2019/12/lbm_2019_10.txt","dataSources":["YYLjupmCazkNqWNEJ"],"keywords":[],"search_terms":["synthesis","biological","evaluation","18f","fluorovinpocetine","potential","pet","radioligand","tspo","imaging","nag","krasikova","airaksinen","arakawa","petukhovd","gulyas"],"title":"Synthesis and biological evaluation of [18F]fluorovinpocetine, a potential PET radioligand for TSPO imaging","year":2019}